HK1061981A1 - Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight - Google Patents

Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight

Info

Publication number
HK1061981A1
HK1061981A1 HK04105106A HK04105106A HK1061981A1 HK 1061981 A1 HK1061981 A1 HK 1061981A1 HK 04105106 A HK04105106 A HK 04105106A HK 04105106 A HK04105106 A HK 04105106A HK 1061981 A1 HK1061981 A1 HK 1061981A1
Authority
HK
Hong Kong
Prior art keywords
molecular weight
controlled release
release administration
reduced molecular
biodegradable microparticles
Prior art date
Application number
HK04105106A
Other languages
English (en)
Inventor
Jonsson Monica
Nils Ove Gustavsson
Timo Laakso
Mats Reslow
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003615A external-priority patent/SE517421C2/sv
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of HK1061981A1 publication Critical patent/HK1061981A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • B01J13/22—Coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04105106A 2000-10-06 2004-07-13 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight HK1061981A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003615A SE517421C2 (sv) 2000-10-06 2000-10-06 Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
US26045501P 2001-01-08 2001-01-08
PCT/SE2001/002164 WO2002028370A1 (en) 2000-10-06 2001-10-05 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight

Publications (1)

Publication Number Publication Date
HK1061981A1 true HK1061981A1 (en) 2004-10-15

Family

ID=26655255

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04105106A HK1061981A1 (en) 2000-10-06 2004-07-13 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight

Country Status (10)

Country Link
US (1) US20020098203A1 (ja)
EP (2) EP1322290A1 (ja)
JP (2) JP2004510723A (ja)
KR (1) KR20030051687A (ja)
CN (1) CN100352427C (ja)
AU (3) AU2001292529A1 (ja)
CA (2) CA2424892A1 (ja)
HK (1) HK1061981A1 (ja)
HU (1) HUP0302622A3 (ja)
WO (2) WO2002028371A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844514B1 (fr) 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
CA2510320C (en) 2002-12-20 2012-10-09 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US7060299B2 (en) 2002-12-31 2006-06-13 Battelle Memorial Institute Biodegradable microparticles that stabilize and control the release of proteins
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
MXPA06012992A (es) * 2004-05-12 2007-02-12 Baxter Int Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
GB0423681D0 (en) * 2004-10-26 2004-11-24 Sec Dep For Environment Food & Vaccine and nucleic acids
US20060269576A1 (en) * 2005-05-27 2006-11-30 Curalogic, A/S Non-injection immunotherapy
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (en) 2005-05-27 2007-04-18 StratoSphere Pharma AB Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2007025441A1 (en) * 2005-08-29 2007-03-08 Tuo Jin Polysaccharide microparticles containing biological agents: there preparation and applications
MX345029B (es) * 2005-10-25 2017-01-13 Artificial Cell Tech Inc Composiciones inmunogénicas y métodos de uso.
US7842312B2 (en) 2005-12-29 2010-11-30 Cordis Corporation Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
KR100956415B1 (ko) * 2008-06-13 2010-05-06 이진호 고분자 구형입자의 제조방법
US9155708B2 (en) 2008-10-10 2015-10-13 Probelte Pharma, S.A. Orally administrable immunostimulant product for aquaculture
JP5361407B2 (ja) * 2009-01-21 2013-12-04 株式会社東芝 Ｘ線画像診断装置、画像処理装置及び制御プログラム
US10188733B2 (en) * 2010-10-22 2019-01-29 President And Fellows Of Harvard College Vaccines comprising bisphosphonate and methods of use thereof
BR112013014574B1 (pt) * 2010-12-15 2019-10-15 Speximo Ab Emulsão ou espuma estabilizada por partícula, uso de uma emulsão estabilizada por partícula e formulação
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
US11470811B2 (en) * 2012-09-11 2022-10-18 Pioneer Pet Products, Llc Extruded granular absorbent
RU2015144689A (ru) 2013-03-21 2017-04-25 ЮПРАКСИЯ ФАРМАСЬЮТИКАЛЗ ЮЭсЭй ЭлЭлСи Композиция для инъекций с замедленным высвобождением и способ ее применения для лечения воспаления в суставах и связанной с такими воспалениями боли
EP2898894A1 (en) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-micro particles for intradermal delivery
WO2017037523A1 (en) * 2015-06-19 2017-03-09 Sillajen, Inc. Compositions and methods for viral embolization
WO2017075232A1 (en) 2015-10-27 2017-05-04 Eupraxia Pharmaceuticals Inc. Sustained release formulations of local anesthetics
CN106902716B (zh) * 2017-02-27 2020-02-14 广西科学院 一种小粒径淀粉微球的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
JPH0699529B2 (ja) * 1985-06-28 1994-12-07 モンサント化成株式会社 シアン化ビニル化合物／芳香族ビニル化合物共重合樹脂の製造方法
CA2136307A1 (en) * 1992-04-20 1993-10-28 Bruce K. Redding, Jr. Method and apparatus for the modification of starch and other polymers
JPH09509161A (ja) * 1994-02-17 1997-09-16 モデイ，パンカイ ポリラクチド被覆ミクロスフィアの状態にある薬物類、ワクチン類及びホルモン類
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US5959102A (en) * 1997-06-30 1999-09-28 Rutgers University Starch purification by thermally tolerant broad pH range proteolytic enzymes
NL1006444C2 (nl) * 1997-07-01 1999-01-05 Inst Voor Agrotech Onderzoek Inkapseling van werkzame stoffen.
SE512663C2 (sv) * 1997-10-23 2000-04-17 Biogram Ab Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer

Also Published As

Publication number Publication date
AU2001292529A1 (en) 2002-04-15
CN1468093A (zh) 2004-01-14
WO2002028370A1 (en) 2002-04-11
AU9445801A (en) 2002-04-15
WO2002028371A1 (en) 2002-04-11
CA2424936A1 (en) 2002-04-11
HUP0302622A3 (en) 2006-07-28
KR20030051687A (ko) 2003-06-25
AU2001294458B2 (en) 2004-03-11
EP1322291A1 (en) 2003-07-02
US20020098203A1 (en) 2002-07-25
EP1322290A1 (en) 2003-07-02
CA2424892A1 (en) 2002-04-11
HUP0302622A2 (hu) 2003-11-28
CN100352427C (zh) 2007-12-05
JP2004510724A (ja) 2004-04-08
JP2004510723A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
AU9445801A (en) Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
HUS1600022I1 (hu) 6-Helyzetben szubsztituált indolinonok, elõállításuk és alkalmazásuk gyógyszerként
HUP0301242A2 (hu) Szabályozott felszabadulású gyógyszer dózis forma
AU6526100A (en) Drug releasing biodegradable fiber implant
EP1175157A4 (en) LOW MOLECULAR WEIGHT POLYMANNURONATE
AU4805200A (en) A bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
NO20021747D0 (no) Blandinger av erytromycinderivater med forlenget frigivelse
HUP0300541A3 (en) Pharmaceutical compositions for sustained release, containing fluvastatin
AUPQ798800A0 (en) Support of loads from garments, carry-packs or the like
HK1047044A1 (en) Use of biodegradable microspheres which release ananticancer agent, for treating glioblasma.
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
AU7815000A (en) Targeted drug activation
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
AU2001248772A1 (en) Sustained release drug compositions
AU2001232948A1 (en) Controlled release of drugs
AU1235701A (en) Molecular weight reduction of olefin copolymers
AUPR951501A0 (en) Modified sustained release pharmaceutical system
EP1443901A4 (en) SYSTEM FOR THE DELAYED RELEASE OF SOLUBLE MEDICAMENTS
AU7456300A (en) Garment hanger
SI1200444T1 (en) Novel xanthone compounds, their preparation and use as medicament
AU7346400A (en) Degradable polymers
HK1045698A1 (zh) 阿維菌素衍生物
AU2001293874A1 (en) System to prevent snoring
MXPA03005792A (es) Composicion farmaceutica solida termoformable para liberacion controlada de perindopril.
AU5414400A (en) 1,4-diazacycloheptane derivatives as neuroprotective agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111005